| Literature DB >> 34159024 |
Deepak Raghavan1, Mathisekaran Thangarasu1, Sanjay Prakash J1, Rajesh Paul1, Nivash Selvaraj1.
Abstract
Purpose Robot-assisted partial nephrectomy (RAPN) has become popular in recent years for small renal masses. We describe a technique of suturing renal defects during RAPN that is reliable and quick, does not necessitate the need for hemostatic agents, and reduces perioperative complications. Materials and methods A total of 24 patients who underwent RAPN were included in the study period between 2013 and 2018 and data were analyzed. Perioperative and postoperative outcomes were measured and compared. Results The median tumor size was 4 cm. Median warm ischemia time was 41 minutes (IQR: 38-45 minutes) and estimated blood loss was 150 mL (IQR: 120-200 mL). There were no major intraoperative complications or conversions to open surgery. No urine leaks or postoperative bleedings were observed. Conclusion Our technique is safe and effective. It negates the use of hemostatic agents, decreases perioperative complications, and negates that determination of long-term renal function is not associated with prolonged warm ischemia time alone. Hence, we propose that our technique is safe in partial nephrectomy when the pelvic calyceal system and renal vessels are opened in multiple locations.Entities:
Keywords: complications; hemostatic; partial nephrectomy; renal function; tumor
Year: 2021 PMID: 34159024 PMCID: PMC8213237 DOI: 10.7759/cureus.15122
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Figure 1Tumor scoring and excision
Figure 2Completion of individual renal vessels ligation and closure of the opened pelvic calyceal system
Figure 3Completion of the inner corticomedullary junction by continuous suture and outer renorraphy with interrupted layer
Demographic profile of the patient (n=24)
ASA, American Society of Anesthesiologists; BMI, body mass index; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; IQR, interquartile range
*eGFR < 60 mL/min/1.73m2
| Characteristics | |
| Age (in years), median (IQR) | 50 (17-59) |
| Gender % (male/female) | 20 (83%)/4 (17%) |
| BMI, median (IQR) | 24.7 (22.9-27.1) |
| ASA grade (1/2/3/4) | 2/6/14/2 |
| CKD stage ≥ 3 (%)* | 4 (17%) |
| Preoperative creatinine (mg/dL), median (IQR) | 0.95 (0.8-1.2) |
| Preoperative eGFR (mL/min/1.73m2), median (IQR) | 90 (66-101) |
| Laterality (right/left), % | 11/13 (46%/54%) |
| Clinical stage | |
| T1a, n | 17 |
| T1b, n | 7 |
| Site | |
| Upper, n | 8 |
| Interpole, n | 6 |
| Lower, n | 10 |
| Renal score, median (IQR) | 5 (4-6) |
Overall perioperative outcome
IQR, interquartile range
| Variables | Median (IQR) |
| Operative time (minutes) | 130 (108-160) |
| Estimated blood loss (mL) | 150 (120-200) |
| Warm ischemic time (minutes) | 41 (38-45) |
| Margin positivity | Nil |
| Pathological diagnosis | |
| Benign | 2 |
| Malignant | 22 |
| Length of stay (days) | 4 (3-5) |
Renal function changes over time
P1: statistical difference between preoperative creatinine value and day 2 creatinine value.
P2: statistical difference between preoperative creatinine value and three-month creatinine value.
P3: statistical difference between preoperative creatinine value and six-month creatinine value.
eGFR, estimated glomerular filtration rate; IQR, interquartile range
| Parameters | Preoperative value | Day 2 | Three months | Six months | P1 | P2 | P3 |
| Creatinine, median (IQR) | 0.9 (0.8-1.2) | 1.5 (1.3-1.5) | 2 (1.3-2.6) | 1.5 (1.2-2.2) | 0.01 | 0.014 | 0.02 |
| eGFR (mL/min/1.73m2), median (IQR) | 90 (67-102) | 49 (36-63) | 37 (30-57) | 50 (29-68) | 0.002 | 0.01 | 0.04 |
Renal function changes over time
P1: statistical difference between preoperative creatinine value and one-year creatinine value.
P2: statistical difference between preoperative creatinine value and two-year creatinine value
eGFR, estimated glomerular filtration rate; IQR, interquartile range
| Parameters | Preoperative value | One year | Two years | P1 | P2 |
| Creatinine, median (IQR) | 0.9 (0.8-1.2) | 1.2 (1.1-1.5) | 1.2 (1.1-1.5) | 0.39 | 0.65 |
| eGFR (mL/min/1.73m2), median (IQR) | 90 (67-102) | 63 (45-73) | 61 (50-78) | 0.47 | 0.32 |